Mylan launches Gilead Sciences’ Sovaldi tablets in India Usha Sharma May 4, 2015 Sovaldi is indicated for the treatment of chronic hepatitis C infection, a blood-borne infectious disease
Mylan signs exclusive agreement with Gilead Sciences Usha Sharma Feb 25, 2015 Under the agreement Mylan will distribute Sovaldi and Harvoni in India
